公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2008 | Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma | Chou Y.-C.; MING-WHEI YU ; Wu C.-F.; Yang S.-Y.; Lin C.-L.; CHUN-JEN LIU ; Shin W.-L.; PEI-JER CHEN ; Liaw Y.-F.; Chen C.-J. | Gut | 101 | 95 | |
2002 | Transfusion-transmitted HBV infection in an endemic area: The necessity of more sensitive screening for HBV carriers | Wang, Jin-Town ; Lee, Cha-Ze ; PEI-JER CHEN ; Wang T-.H.; DING-SHINN CHEN | Transfusion | 68 | 66 | |
1994 | Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: A true risk and occasional coinfection with hepatitis C virus shown in a prospective study | Wang, Jin-Town ; Lin M.-T.; PEI-JER CHEN ; JIN-CHUAN SHEU ; Lin J.-T.; Wang T.-H.; DING-SHINN CHEN | Blood | 11 | 12 | |
2011 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients | CHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical journal of the American Society of Nephrology : CJASN | 71 | 69 | |
1992 | Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: Putative serological marker for acute viral infection | PEI-JER CHEN ; JIN-TOWN WANG ; Hwang L.-H.; Yang Y.-H.; Hsieh C.-L.; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 61 | 59 | |
1996 | Transmission of hepatitis C virus between spouses: The important role of exposure duration | JIA-HORNG KAO ; Hwang Y.-T.; PEI-JER CHEN ; PEI-MING YANG ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | American Journal of Gastroenterology | 83 | 66 | |
2006 | Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan | CHUN-JEN LIU ; SHYH-CHYI LO ; JIA-HORNG KAO ; Tseng P.-T.; Lai M.-Y.; YEN-HSUAN NI ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 98 | 88 | |
2013 | Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: The emerging role for radioembolization using yttrium-90 | Lau W.-Y.; Sangro B.; PEI-JER CHEN ; Cheng S.-Q.; Chow P.; Lee R.-C.; Leung T.; Han K.-H.; Poon R.T.P. | Oncology (Switzerland) | 127 | 121 | |
2015 | Treatment of liver cancer | Liu C.-Y.; Chen K.-F.; PEI-JER CHEN | Cold Spring Harbor Perspectives in Medicine | 244 | 200 | |
2014 | Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality | CHUN-JEN LIU ; Chu, Y.-T.; Shau, W.-Y.; Kuo, R.N.; PEI-JER CHEN ; Lai, M.-S. | Gut | 46 | 39 | |
2005 | Trichuris suis therapy for ulcerative colitis: Nonresponsive patients may need anti-helminth therapy [2] (multiple letters) | SHIH-JER HSU ; PING-HUEI TSENG ; PEI-JER CHEN ; Summers R.W.; Elliott D.E.; Weinstock J.V. | Gastroenterology | 13 | 12 | |
2000 | TT virus infection in patients with chronic hepatitis B or C: Influence on clinical, histological and virological features | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 36 | | |
2015 | Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model | Chyuan I.-T.; Tsai H.-F.; Tzeng H.-T.; Sung C.-C.; Wu C.-S.; PEI-JER CHEN ; PING-NING HSU | Cellular and Molecular Immunology | 22 | 20 | |
2014 | Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model | Tzeng H.-T.; Tsai H.-F.; Chyuan I.-T.; Liao H.-J.; Chen C.-J.; PEI-JER CHEN ; PING-NING HSU | PLoS ONE | 50 | 46 | |
2020 | Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials | Asahina Y.; CHUN-JEN LIU ; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN ; Enomoto N. | Hepatology Research | 6 | 6 | |
1995 | Unbiased usage of T‐cell receptor β variable region genes in peripheral blood cells of hepatitis C patients: No correlation with superantigen effect | Wang C.C.; Hwang L.H.; DING-SHINN CHEN ; PEI-MING YANG ; BOR-LUEN CHIANG ; PEI-JER CHEN | Journal of Medical Virology | 3 | 4 | |
2018 | The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice | Kang X.-Z.; Guo X.-R.; Chen B.-B.; Zhang T.-Y.; Yuan Q.; PEI-JER CHEN ; Zhang J.; Xia N.-S. | Human Vaccines and Immunotherapeutics | 3 | 3 | |
2020 | A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice | Zhang T.-Y.; Guo X.-R.; Wu Y.-T.; Kang X.-Z.; Zheng Q.-B.; Qi R.-Y.; Chen B.-B.; Lan Y.; Wei M.; Wang S.-J.; Xiong H.-L.; Cao J.-L.; Zhang B.-H.; Qiao X.-Y.; Huang X.-F.; Wang Y.-B.; Fang M.-J.; Zhang Y.-L.; Cheng T.; Chen Y.-X.; Zhao Q.-J.; Li S.-W.; Ge S.-X.; PEI-JER CHEN ; Zhang J.; Yuan Q.; Xia N.-S. | Gut | 28 | 27 | |
2021 | Unique features of hepatitis b virus-related hepatocellular carcinoma in pathogenesis and clinical significance | Wang S.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN | Cancers | 11 | 11 | |
2014 | Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection | CHUN-JEN LIU ; PEI-JER CHEN | World Journal of Gastroenterology | 21 | 19 | |